Cardiomyopathies (CMPs) represent a diverse group of heart muscle diseases, grouped into specific morphological and functional phenotypes. CMPs are associated with mutations in sarcomeric and non-sarcomeric genes, with several suspected epigenetic and environmental mechanisms involved in determining penetrance and expressivity. The understanding of the underlying molecular mechanisms of myocardial diseases is fundamental to achieving a proper management and treatment of these disorders. Among these, inflammation seems to play an important role in the pathogenesis of CMPs. The aim of the present study is to review the current knowledge on the role of inflammation and the immune system activation in the pathogenesis of CMPs and to identify potential molecular targets for a tailored anti-inflammatory treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554875 | PMC |
| http://dx.doi.org/10.3390/ijms21186462 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epigenetics of cardiomyopathies: the next frontier.
Heart Fail Rev
January 2025
Thoraxcenter, Department of Cardiology, Cardiovascular Institute. Erasmus MC - University Medical Center Rotterdam, Office RG-431Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Cardiomyopathies (CMP) are a diverse group of myocardial diseases that cause structural, functional, and pathological changes to the heart. Alterations at the molecular level associated with the clinical phenotype and progression of CMPs cannot be solely explained by the genetic mutations, even in inherited cardiomyopathies. Epigenetics and environmental factors are likely to significantly modify the clinical manifestations of CMPs, resulting in variable clinical expression and different age-related penetrance.
View Article and Find Full Text PDFUnveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review.
Int J Mol Sci
September 2024
S. Andrea University Hospital, 00189 Rome, Italy.
Hereditary cardiomyopathies (CMPs), including arrhythmogenic cardiomyopathy (ACM), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM), represent a group of heart disorders that significantly contribute to cardiovascular morbidity and mortality and are often driven by genetic factors. Recent advances in next-generation sequencing (NGS) technology have enabled the identification of rare variants in both well-established and minor genes associated with CMPs. Nowadays, a set of core genes is included in diagnostic panels for ACM, DCM, and HCM.
View Article and Find Full Text PDFPotential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology.
J Gastrointest Oncol
August 2024
Department of Gastroenterology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
Article Synopsis
- Gastric cancer (GC) is a major global health concern, known for its high mortality rates and challenges in treatment due to its complex tumor microenvironment and metabolic variations.
- Cimifugin, a traditional Chinese medicine, shows promise in cancer treatment by targeting multiple pathways with few side effects, prompting research into its effects on GC's microenvironment and metabolism.
- The study found that cimifugin significantly inhibited the proliferation, migration, and invasion of gastric cancer cells, suggesting its potential as a therapeutic strategy that could enhance treatment efficacy.
Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes.
Genes (Basel)
August 2024
Laboratory of Medical Genetics, B.V. Petrovsky Russian Research Center of Surgery, 119991 Moscow, Russia.
Article Synopsis
- The study investigated post-COVID myocarditis in 10 patients with various cardiomyopathies (CMPs) following COVID-19 infection, focusing on their clinical outcomes.
- A range of CMPs were identified in the patients, including left ventricular non-compaction, dilated cardiomyopathy, and AL cardiac amyloidosis, with all undergoing detailed cardiac evaluations.
- Post-COVID myocarditis was confirmed in six patients, showing improvements in heart function when treated with immunosuppressive corticosteroids; this highlighted the importance of monitoring arrhythmias and heart failure in CMP patients after COVID-19.
Microplastic dilemma: Assessing the unexpected trade-offs between biodegradable and non-biodegradable forms on plant health, cadmium uptake, and sediment microbial ecology.
J Hazard Mater
September 2024
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Article Synopsis
- - The study investigates the environmental effects of biodegradable plastics (BPs) vs. conventional plastics (CPs) as microplastics (MPs) on plant health, cadmium absorption, and soil bacteria.
- - Results indicate that both types of MPs hinder plant growth, but BPs cause greater damage by increasing oxidative stress and changing soil microbial functions more than CPs.
- - Key findings highlight that BPs enhance cadmium uptake in plants and significantly alter bacterial communities, pointing to greater ecological risks from biodegradable materials compared to conventional options.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!